Vascular wall, dynamics and estrogen

References

• Chester A. H., Jiang C., Borland J. A., Yacoub M. H., Collins P. Estrogen relaxes human epicardial coronary arteries through nonendothelium-dependent mechanisms. Cor. Art. Dis. 1995; 6: 417–22
   PubMed Web of Science ®Google Scholar
• Collins P., Shay J., Jiang C., Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation following acute estrogen withdrawal. Circulation 1994; 90: 1964–8
   PubMed Web of Science ®Google Scholar
• Reis S. E., Gloth S. T., Blumenthal R. S., Resar J. R., Zacur H. A., Gerstenblith G., Brinker J. A. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Ciculation 1994; 89: 52–60
   PubMed Web of Science ®Google Scholar
• Gilligan D. M., Quyyumi A. A., Cannon R. O., III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545–51
   PubMed Web of Science ®Google Scholar
• Collins P., Rosano G. M. C., Sarrel P. M., Ulrich L., Adamopoulos S., Beale C. M., McNeill J., Poole-Wilson P. A. Estradlol-17β attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24–30
   PubMed Web of Science ®Google Scholar
• Jiang C., Poole-Wilson P. A., Sarrel P. M., Mochizuki S., Collins P., MacLeod K. T. Effect of 17β-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guineapig isolated cardiac myocytes. Br. J. Pharmacol. 1992; 106: 739–45
   PubMed Web of Science ®Google Scholar
• Adams M. R., Kaplan J. R., Manuck S. B., Koritnik D. R., Parks J. S., Wolfe M. S., Clarkson T. B. Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990; 10: 1050–7
   Google Scholar
• Wagner J. D., Clarkson T. B., St Clair R. W., Schwenke D. C., Shively C. A., Adams M. R. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J. Clin. Invest. 1991; 88: 1995–2002
   PubMed Web of Science ®Google Scholar
• Gruchow H. W., Anderson A. J., Barboriak J. J., Sobocinski K. A. Postmenopausal use of estrogen and occlusion of coronary arteries. Am. Heart J. 1988; 115: 954–63
   PubMed Web of Science ®Google Scholar
• Sullivan J. M., Vander Zwaag R., Lemp G. F., Hughes J. P., Maddock V., Kroetz F. W., Ramanathan K. B., Mirvis D. M. Postmenopausal estrogen use and coronary atherosclerosis. Ann. Intern. Med. 1988; 108: 358–63
   PubMed Web of Science ®Google Scholar
• Mendelsohn M. E., Karas R. H. Estrogen and the blood vessel wall. Curr. Opin. Cardiol. 1994; 9: 619–26
   PubMed Web of Science ®Google Scholar
• Shay J., Badrov N., Attele A., Levinson M., Moss J. Estrogen antagonises endothelin-1 vasoconstriction in rabbit basilar artery. Anesth. Analg. 1993; A561
   Google Scholar
• Jiang C., Sarrel P. M., Poole-Wilson P. A., Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am. J. Physiol. 1992; 263: H271–H275
   PubMed Web of Science ®Google Scholar
• Cheng D. Y., Gruetter C. A. Chronic estrogen alters contractile responsiveness to angiotensin II and norepinephrine in female rat aorta. Eur. J. Pharmacol. 1992; 215: 171–6
   PubMed Web of Science ®Google Scholar
• Magness R. R., Parker C. R., Jr., Rosenfeld C. R. Systemic and uterine responses to chronic infusion of estradiol-17β. Am. J. Physiol. 1993; 265: E690–E698
   Google Scholar
• Brosnihan K. B., Weedle D., Athony M. S., Ferrario C. M. Does chronic estrogen act as a converting enzyme inhibitor in postmenopausal cynomolgus monkeys. Am. J. Hypertens. 1995; 8: 107A, (Abstract)
   Google Scholar
• Prouder A. J., Hasib Ahmed A. I., Crook D., Fogelman I., Rymer J. M., Stevenson J. C. Hormone replacement therapy and serum agiotensin-converting-enzyme activity in postmenopausal women. Lancet 1995; 346: 89–90
   Google Scholar
• Weiner C. P., Lizasoain I., Baylis S. A., Knowles R. G., Charles I. G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA 1994; 91: 5212–16
   PubMed Web of Science ®Google Scholar
• Dubey R. K., Overbeck H. W. Culture of rat mesenteric arteriolar smooth muscle cells: effects of platelet-derived growth factor, angiotensin, and nitric oxide on growth. Cell Tissue Res. 1994; 275: 133–41
   Google Scholar
• Sack M. N., Rader D. J., Cannon R. O., III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994; 343: 269–70
   PubMed Web of Science ®Google Scholar
• Simon B. C., Cunningham L. D., Cohen R. A. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J. Clin. Invest. 1990; 86: 75–9
   PubMed Web of Science ®Google Scholar
• Caulin-Glaser T. L., Sessa W., Sarrel P., Bender J. The effect of 17β-estradiol on human endothelial cell nitric oxide production. Circulation 1994; 90: 1–30, (Abstract)
   Google Scholar
• Kharitonov S. A., Logan-Sinclair R. B., Busset C. M., Shinebourne E. A. Peak expiratory nitric oxide differences in men and women: relation to the menustrual cycle. Br. Heart J. 1994; 72: 243–5
   PubMedGoogle Scholar
• Brosnihan K. B., Moriguchi A., Nakamoto H., Dean R. H., Ganten D., Ferrario C. M. Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene. Am. J. Hypertens. 1994; 7: 576–82
   Google Scholar
• Van Buren G., Yang D., Clark K. E. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am. J. Obstet, Gynecol. 1992; 16: 828–33
   Google Scholar
• Williams J. K., Adams M. R., Herrington D. M., Clarkson T. B. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J. Am. Coll. Cardiol. 1992; 20: 452–7
   PubMed Web of Science ®Google Scholar
• Lieberman E. H., Gerhard M. D., Uehata A., Walsh B. W., Selwyn A. P., Ganz P., Yeung A. C., Creager M. A. Estrogen improves endothelium-dependent, flow-mediated vasodilatation in postmenopausal women. Ann. Intern. Med. 1994; 121: 936–41
   PubMed Web of Science ®Google Scholar
• Jiang C., Sarrel P. M., Lindsay D. C., Poole-Wilson P. A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br. J. Pharmacol. 1991; 104: 1033–7
   PubMed Web of Science ®Google Scholar
• Mügge A., Riedel M., Barton M., Khun M., Lichten P. R. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc. Res. 1993; 27: 1939–42
   PubMed Web of Science ®Google Scholar
• Han S. Z., Karaki H., Ouch Y., Akishita M., Orimo H. 17β-estradol inhibits Ca2+ influx and Ca2+ release induced by thromboxane A2 in porcine coronary artery. Circulation 1995; 91: 2619–26
   PubMed Web of Science ®Google Scholar
• Zhang F., Ram J. L., Standley P. R., Sowers J. R. 17β-estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am. J. Physiol. 1994; 266: C975–C980
   PubMed Web of Science ®Google Scholar
• Hardy S. P., Valverde M. A. Novel plasma membrane action of estrogen and antiestrogens revealed by their regulation of a large conductance chloride channel. FASEBJ. 1994; 8: 760–5
   Google Scholar
• Collins P., Rosano G. M. C., Jiang C., Lindsay D., Sarrel P. M., Poole-Wilson P. A. Hypothesis: cardiovascular protection by oestrogen — a calcium antagonist effect. Lancet 1993; 341: 1264–5
   PubMed Web of Science ®Google Scholar
• Lichtlen P. R., Hugenholtz P. G., Rafflenbeul W., Hecker H., Jost S., Deckers J. W. Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 1990; 335: 1109–13
   PubMed Web of Science ®Google Scholar
• Waters D., Lesperance J., Francetich M., et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990; 82: 1940–53
   PubMed Web of Science ®Google Scholar
• Botting R., Vane J. R. The receipt and dispatch of chemical messengers by endothelial cells. Prostaglandins in Clinical Research: Cardiovascular System, K. Schrör, H. Sinzinger. Alan R. Liss, Inc., New York 1989; 1–11
   Google Scholar
• Chang W. C., Nakao J., Orimo H., Murota S. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochim. Biophys. Acta 1980; 619: 107–18
   PubMed Web of Science ®Google Scholar
• Mikkola T., Turunen P., Avela K., Orpana A., Viinikka L., Ylikorkala O. 17β-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J. Clin. Endorcrinol. Metab. 1995; 80: 1832–6
   PubMed Web of Science ®Google Scholar
• Lerman A., Webster M. W. I., Chesebro J. H., Edwards W. D., Wei C-M., Fuster V., Burnett J. C., Jr. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 1993; 88: 2923–8
   Google Scholar
• Losordo D. W., Kearney M., Kim E. A., Jekanowski J., Her J. M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501–10
   PubMed Web of Science ®Google Scholar